Format
Items per page
Sort by

Send to:

Choose Destination

Results: 6

Cited In for PubMed (Select 15664103)

1.

Cost effectiveness of primary care referral to a commercial provider for weight loss treatment, relative to standard care: a modelled lifetime analysis.

Fuller NR, Carter H, Schofield D, Hauner H, Jebb SA, Colagiuri S, Caterson ID.

Int J Obes (Lond). 2014 Aug;38(8):1104-9. doi: 10.1038/ijo.2013.227. Epub 2013 Dec 4.

2.

Bariatric surgery as potential treatment for nonalcoholic fatty liver disease: a future treatment by choice or by chance?

Hafeez S, Ahmed MH.

J Obes. 2013;2013:839275. doi: 10.1155/2013/839275. Epub 2013 Jan 29. Review.

3.

A within-trial cost-effectiveness analysis of primary care referral to a commercial provider for weight loss treatment, relative to standard care--an international randomised controlled trial.

Fuller NR, Colagiuri S, Schofield D, Olson AD, Shrestha R, Holzapfel C, Wolfenstetter SB, Holle R, Ahern AL, Hauner H, Jebb SA, Caterson ID.

Int J Obes (Lond). 2013 Jun;37(6):828-34. doi: 10.1038/ijo.2012.139. Epub 2012 Aug 28.

4.

Short-term outcome and quality of life of endoscopically placed gastric balloon and laparoscopic adjustable gastric band.

Tayyem RM, Obondo C, Ali A.

Saudi J Gastroenterol. 2011 Nov-Dec;17(6):400-5. doi: 10.4103/1319-3767.87182.

5.

The use of serotonergic drugs to treat obesity--is there any hope?

Bello NT, Liang NC.

Drug Des Devel Ther. 2011 Feb 10;5:95-109. doi: 10.2147/DDDT.S11859. Review.

6.

Factors associated with weight loss after gastric bypass.

Campos GM, Rabl C, Mulligan K, Posselt A, Rogers SJ, Westphalen AC, Lin F, Vittinghoff E.

Arch Surg. 2008 Sep;143(9):877-883; discussion 884. doi: 10.1001/archsurg.143.9.877.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk